STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS
    1.
    发明申请
    STABILIZED OPHTHALMIC GALACTOMANNAN FORMULATIONS 审中-公开
    稳定的眼药水制剂

    公开(公告)号:US20110275593A1

    公开(公告)日:2011-11-10

    申请号:US13100439

    申请日:2011-05-04

    IPC分类号: A61K31/736 A61P27/04

    摘要: The present invention relates to viscosity stabilized ophthalmic formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a diol alcohol such as sorbitol and, optionally, a pharmaceutically acceptable divalent cation salt such as magnesium chloride.

    摘要翻译: 本发明涉及适用于药物递送的粘度稳定的眼用制剂和眼用制剂。 制剂包含半乳甘露聚糖,例如瓜尔胶或羟丙基瓜尔胶,硼酸盐如硼酸。 制剂还包含二醇醇,例如山梨醇和任选的药学上可接受的二价阳离子盐如氯化镁。

    Polymeric artificial tear system
    5.
    发明授权
    Polymeric artificial tear system 有权
    聚合人工泪液系统

    公开(公告)号:US08685945B2

    公开(公告)日:2014-04-01

    申请号:US13302439

    申请日:2011-11-22

    IPC分类号: A61K31/70

    摘要: The present invention relates to artificial tear formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a cis-diol such as sorbitol that interferes with the cross-linking of galactomannan and borate. Optionally, the formulations are substantially free of divalent cations.

    摘要翻译: 本发明涉及适于药物递送的人造泪液制剂和眼用制剂。 制剂包含半乳甘露聚糖,例如瓜尔胶或羟丙基瓜尔胶,硼酸盐如硼酸。 制剂还包含干扰半乳甘露聚糖和硼酸盐的交联的顺式二醇如山梨糖醇。 任选地,制剂基本上不含二价阳离子。

    POLYMERIC ARTIFICIAL TEAR SYSTEM
    7.
    发明申请
    POLYMERIC ARTIFICIAL TEAR SYSTEM 有权
    聚合物人造系统

    公开(公告)号:US20120070402A1

    公开(公告)日:2012-03-22

    申请号:US13302439

    申请日:2011-11-22

    IPC分类号: A61K31/736 A61P27/04

    摘要: The present invention relates to artificial tear formulations and ophthalmic formulations suitable for drug delivery. The formulations comprise galactomannans such as guar or hydroxypropyl guar and a borate source such as boric acid. The formulations further comprise a cis-diol such as sorbitol that interferes with the cross-linking of galactomannan and borate. Optionally, the formulations are substantially free of divalent cations.

    摘要翻译: 本发明涉及适于药物递送的人造泪液制剂和眼用制剂。 制剂包含半乳甘露聚糖,例如瓜尔胶或羟丙基瓜尔胶,硼酸盐如硼酸。 制剂还包含干扰半乳甘露聚糖和硼酸盐的交联的顺式二醇如山梨糖醇。 任选地,制剂基本上不含二价阳离子。

    Use of PBO-PEO-PBO block copolymers in ophthalmic compositions
    8.
    发明授权
    Use of PBO-PEO-PBO block copolymers in ophthalmic compositions 有权
    在眼科组合物中使用PBO-PEO-PBO嵌段共聚物

    公开(公告)号:US08999312B2

    公开(公告)日:2015-04-07

    申请号:US13151991

    申请日:2011-06-02

    摘要: The use of poly(oxybutylene)-poly(oxyethylene)-poly(oxybutylene) block copolymers in pharmaceutical compositions useful, for modifying the surfaces of contact lenses and other medical devices is disclosed. The present invention is based in-part on a discovery that this class of compounds is particularly efficient in wetting hydrophobic surfaces, such as the surfaces of silicone hydrogel contact lenses and other types of ophthalmic lenses, but do not induce foaming when used in conjunction with a peroxide-based contact lens disinfection regimen. Such compounds may also be useful for cleaning purposes. The use of the compounds as surfactants in peroxide-based compositions for disinfecting contact lenses therefore represents a preferred embodiment of the present invention.

    摘要翻译: 公开了在用于改性隐形眼镜和其它医疗装置的表面的药物组合物中使用聚(氧丁烯) - 聚(氧乙烯) - 聚(氧丁烯) - 嵌段共聚物。 本发明部分地基于以下发现,即这类化合物在润湿疏水性表面(例如硅酮水凝胶隐形眼镜和其它类型的眼科镜片的表面)中特别有效,但是当与 一种基于过氧化物的隐形眼镜消毒方案。 这样的化合物也可用于清洁目的。 因此,作为用于消毒隐形眼镜的过氧化物基组合物中的化合物作为表面活性剂的使用是本发明的优选实施方案。

    USE OF PBO-PEO-PBO BLOCK COPOLYMERS IN OPHTHALMIC COMPOSITIONS
    9.
    发明申请
    USE OF PBO-PEO-PBO BLOCK COPOLYMERS IN OPHTHALMIC COMPOSITIONS 有权
    PBO-PEO-PBO嵌段共聚物在眼用组合物中的应用

    公开(公告)号:US20110300019A1

    公开(公告)日:2011-12-08

    申请号:US13151991

    申请日:2011-06-02

    IPC分类号: A61L2/18 A01P1/00 A01N59/00

    摘要: The use of poly(oxybutylene)-poly(oxyethylene)-poly(oxybutylene) block copolymers in pharmaceutical compositions useful, for modifying the surfaces of contact lenses and other medical devices is disclosed. The present invention is based in-part on a discovery that this class of compounds is particularly efficient in wetting hydrophobic surfaces, such as the surfaces of silicone hydrogel contact lenses and other types of ophthalmic lenses, but do not induce foaming when used in conjunction with a peroxide-based contact lens disinfection regimen. Such compounds may also be useful for cleaning purposes. The use of the compounds as surfactants in peroxide-based compositions for disinfecting contact lenses therefore represents a preferred embodiment of the present invention.

    摘要翻译: 公开了在用于改性隐形眼镜和其它医疗装置的表面的药物组合物中使用聚(氧丁烯) - 聚(氧乙烯) - 聚(氧丁烯) - 嵌段共聚物。 本发明部分地基于以下发现,即这类化合物在润湿疏水性表面(例如硅酮水凝胶隐形眼镜和其它类型的眼科镜片的表面)中特别有效,但是当与 一种基于过氧化物的隐形眼镜消毒方案。 这样的化合物也可用于清洁目的。 因此,作为用于消毒隐形眼镜的过氧化物基组合物中的化合物作为表面活性剂的使用是本发明的优选实施方案。